Physician
University Cancer & Blood Center, LLC
University Cancer & Blood Center, LLC was paid $3.24M by Medicaid between Jan 2018 and Dec 2024, across 57 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 31% of everything it billed.
33Billing provider infoUNIVERSITY CANCER & BLOOD CENTER, LLC
ATHENS, GA 30607
ATHENS, GA 30607
33aNPI1346343761assigned 09/07/2006
33bProvider typeHospice and Palliative Medicine (Family Medicine) Physician
28Total paid$3.24M
24GClaims207,439
24DCodes billed57
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 28,173 | $483K | |
| 2019 | 34,732 | $348K | |
| 2020 | 32,278 | $652K | |
| 2021 | 30,655 | $505K | |
| 2022 | 30,262 | $465K | |
| 2023 | 36,831 | $558K | |
| 2024incomplete | 14,508 | $230K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 31% | 36,057 | 25,602 | $1.02M |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 18% | 3,303 | 591 | $590K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 17% | 8,630 | 4,993 | $562K |
| 77014 | 8.5% | 4,044 | 715 | $277K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.4% | 34,115 | 23,908 | $175K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.9% | 2,612 | 1,870 | $94K |
| 96367 | 2.4% | 2,717 | 1,471 | $78K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.0% | 4,228 | 3,471 | $66K |
| 77427 | 1.7% | 710 | 436 | $54K | |
| APT16 | 1.6% | 4,543 | 3,345 | $53K | |
| 77336 | 1.6% | 919 | 580 | $50K | |
| 80053 | Comprehensive metabolic panel | 1.2% | 17,376 | 12,978 | $38K |
45 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,846 | $30K |
| 77334 | <1% | 135 | $23K | |
| 83615 | <1% | 18,301 | $14K | |
| 82728 | <1% | 1,262 | $13K | |
| 84550 | <1% | 18,265 | $11K | |
| 82607 | <1% | 754 | $10K | |
| 82746 | <1% | 695 | $9K | |
| 83550 | <1% | 1,213 | $8K | |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | <1% | 56 | $8K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | <1% | 17 | $8K |
| J0897 | Injection, denosumab, 1 mg | <1% | 16 | $7K |
| 83540 | <1% | 1,206 | $6K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 440 | $5K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 67 | $5K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 133 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 24,258 | $4K |
| 96417 | <1% | 78 | $3K | |
| 77263 | <1% | 39 | $3K | |
| 85045 | <1% | 676 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,564 | $2K |
| 77300 | <1% | 13 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 115 | $2K |
| 82533 | <1% | 81 | $1K | |
| 84439 | <1% | 145 | $1K | |
| 80076 | <1% | 230 | $916.20 | |
| APT02 | <1% | 128 | $812.80 | |
| 83735 | <1% | 56 | $421.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 901 | $405.23 |
| 90686 | <1% | 15 | $234.96 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 344 | $187.53 |
| 80047 | <1% | 19 | $178.49 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 16 | $158.09 |
| J9045 | Injection, carboplatin, 50 mg | <1% | 28 | $156.97 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 30 | $150.42 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 105 | $98.29 |
| 1036F | <1% | 7,053 | $94.70 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 48 | $34.49 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 74 | $27.34 |
| 36416 | <1% | 2,216 | $8.40 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 102 | $7.65 |
| J3490 | Unclassified drugs | <1% | 23 | $0.92 |
| 4004F | 0% | 1,256 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 29 | $0.00 |
| 99443 | 0% | 106 | $0.00 | |
| 80050 | General health panel | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGOODSON, LORETTA (ADMINISTRATOR)